A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Incyte Corporation
Incyte Corporation
Janssen Research & Development, LLC
University of California, Irvine
Hoffmann-La Roche
Tizona Therapeutics, Inc
Novartis
Incyte Corporation
Debiopharm International SA
University of Alabama at Birmingham
Sapience Therapeutics
IGM Biosciences, Inc.